Sahasrabudhe D M
Cancer Center, University of Rochester School of Medicine and Dentistry, New York 14642.
J Exp Med. 1987 Nov 1;166(5):1573-8. doi: 10.1084/jem.166.5.1573.
We have presented data showing that IFN-beta at 1,000 U/mouse i.v. inhibits the generation of Ts-mediated tolerance to dinitrofluorobenzene (DNFB) and abrogates the transfer of suppression by Ts. We have also presented data showing that IFN-beta up to 10,000 U/mouse i.v. has no adverse effect on sensitization and elicitation. IFN-beta appears to be a suitable agent for evaluation as an adjunct in the immunotherapy of Ts inducing tumors.
我们已经展示的数据表明,静脉注射1000 U/只小鼠的干扰素β可抑制Ts介导的对二硝基氟苯(DNFB)耐受性的产生,并消除Ts介导的抑制作用的传递。我们还展示的数据表明,静脉注射高达10000 U/只小鼠的干扰素β对致敏和激发均无不良影响。干扰素β似乎是一种适合作为诱导Ts的肿瘤免疫治疗辅助药物进行评估的药物。